Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC)
Authors:
- Ana Luisa Godoy FernandesAFAna Luisa Godoy Fernandes
- José Rodrigues PereiraJPJosé Rodrigues Pereira
- J Randall CurtisJCJ Randall Curtis
- Ilka Lopes SantoroISIlka Lopes Santoro
- 1 August 2006
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 53 (2) , 171-176
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical TrialsThe Oncologist, 2005
- Management of Lung Cancer in Older AdultsCA: A Cancer Journal for Clinicians, 2003
- Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 2003
- Chemotherapy for elderly patients with advanced non-small-cell lung cancer.JNCI: Journal of the National Cancer Institute, 2003
- Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized TrialJNCI: Journal of the National Cancer Institute, 2002
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Entry and evaluation of elderly patients in european organization for research and treatment of cancer (EORTC) new-drug–development studiesCancer, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958